Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2612-2025Class I

Reprocessed Inquiry Steerable Diagnostics Catheter for electrogram recording and cardiac stimulation during...

MEDLINE INDUSTRIES, LP - Northfield / initiated 2025-07-31 / Open, Classified

Medline Industries, LP began a recall of Reprocessed Inquiry Steerable Diagnostics Catheter for electrogram recording and cardiac stimulation during diagnostic electrophysiologic studies; Medline Item... on . FDA classified it as Class I and gives the reason as "Specific lots of reprocessed electrophysiology and ultrasound catheters may contain small residual particulates. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2612-2025
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
Reprocessed Inquiry Steerable Diagnostics Catheter for electrogram recording and cardiac stimulation during diagnostic electrophysiologic studies; Medline Item Numbers 81102RH 81104RH 81107RH 81174RH 81402RH 81404RH 81405RH 81472RH 81473RH 81474RH 81531RH 81532RH
Product code
NLH Catheter, Recording, Electrode, Reprocessed
Reason for recall
Specific lots of reprocessed electrophysiology and ultrasound catheters may contain small residual particulates. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk of an inflammatory response or systemic infection, and if particulate were to dislodge during use and contact circulating blood and/or the heart, it may produce a granulomatous reaction or thrombus formation, which may lead to cerebral or pulmonary embolism, or deep vein thrombosis.
FDA root cause
Under Investigation by firm
Action
On July 31, 2025, the firm notified customers via first class mail and email of the potential product issue. An updated letter was sent to customers on 8/13/25 with additional item and lot numbers. Affected products are to be returned for credit. Customers were instructed to immediately identify and quarantine all affected product within their possession. Once they have completed and returned the response form listing their affected inventory, they will receive return labels and RGA information. Customers will receive credit when the returned product is received.
Quantity in commerce
7913 eaches
Distribution
Domestic US distribution nationwide. International distribution pending. No international distribution.
Product codes and lots
Item Number/UDI-DI 81102RH 10197344133239; 81104RH 10197344133246; 81107RH 10197344133260; 81174RH 10197344133291; 81402RH 10197344133352; 81404RH 10197344133376; 81405RH 10197344133383; 81472RH 10197344133413; 81473RH 10197344133420; 81474RH 10197344133437; 81531RH 10197344133512; 81532RH 10197344133529; LOTS EP250212 EP250214

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2612-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2610-2025Class IOngoingVoluntary: Firm initiated
Z-2611-2025Class IOngoingVoluntary: Firm initiated
Z-2612-2025Class IOngoingVoluntary: Firm initiated
Z-2613-2025Class IOngoingVoluntary: Firm initiated
Z-2614-2025Class IOngoingVoluntary: Firm initiated